[1]
Al-Hatemy, M.D.B. and Mohsin, M.I. 2022. Evaluating the levels of interleukin-6 and interleukin-10 as potential biomarkers for the severity and mortality in COVID-19 patients. International journal of health sciences. 6, S8 (Jun. 2022), 294–310. DOI:https://doi.org/10.53730/ijhs.v6nS8.9714.